Class 2 Medicines Recall: Novartis Pharmaceuticals UK, Lucentis 10 mg/ml solution for injection in pre
HomeHome > News > Class 2 Medicines Recall: Novartis Pharmaceuticals UK, Lucentis 10 mg/ml solution for injection in pre

Class 2 Medicines Recall: Novartis Pharmaceuticals UK, Lucentis 10 mg/ml solution for injection in pre

Jun 06, 2024

Novartis Pharmaceuticals UK are recalling the above batch due to a faulty plunger stopper which has led to an increased number of customer complaints relating to the plunger being difficult to press down. The faulty plunger stopper batch has only been used in batch 21B15IA and no other batches of Lucentis are impacted.

MDR 017-12/21

Novartis Pharmaceuticals UK

Lucentis 10 mg/ml solution for injection in pre-filled syringe, 5ml, (PLGB 00101/1103 EU/1/06/374/003)

Active Pharmaceutical Ingredient: Ranibizumab

Novartis Pharmaceuticals UK are recalling the above batch due to a faulty plunger stopper which has led to an increased number of customer complaints relating to the plunger being difficult to press down. The faulty plunger stopper batch has only been used in batch 21B15IA and no other batches of Lucentis are impacted.

Stop supplying the above batch immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

For more information or medical information queries, please contact: 01276 698370, or email [email protected]

For stock control queries, please contact: 08457 419442, or email [email protected]

Recipients of this Medicines Recall should bring it to the attention of relevant contacts by copy of this notice. NHS regional teams are asked to forward this to community pharmacists and dispensing general practitioners for information.

Class 2 Medicines Recall: Novartis Pharmaceuticals UK, Lucentis 10 mg/ml solution for injection in pre-filled syringe EL (21)A/36